Skip to content

Drug interactions

Imatinib + Pimavanserin

Severity: Moderate

Imatinib and Pimavanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib may raise pimavanserin concentrations through CYP3A4 inhibition, increasing the risk of QT prolongation. Both drugs have been linked to QT effects.

What this interaction means in plain words

Imatinib and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Pimavanserin belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by imatinib reduces pimavanserin clearance, with possible additive QT effects.

What to do

Consider reducing the pimavanserin dose and monitor ECG, especially with other QT-prolonging risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Pimavanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Pimavanserin?

MediHelp rates the interaction as moderate. Imatinib and Pimavanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib may raise pimavanserin concentrations through CYP3A4 inhibition, increasing the risk of QT prolongation. Both drugs have been linked to QT effects.

How serious is the interaction between Imatinib and Pimavanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the pimavanserin dose and monitor ECG, especially with other QT-prolonging risk factors.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in